X-inactivation analysis in the 1990s: promise and potential problems

Impact of clonal hematopoiesis on cardiovascular outcomes in cancer patients of the UK Biobank.

ESMO open·2025

Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients.

Blood cancer journal·2020

Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients.

Blood cancer journal·2017

Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation.

Bone marrow transplantation·2015

Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms.

Blood cancer journal·2012

EXEL-8232, a small-molecule JAK2 inhibitor, effectively treats thrombocytosis and extramedullary hematopoiesis in a murine model of myeloproliferative neoplasm induced by MPLW515L.

Leukemia·2011

DNA methylation signatures distinguish extranodal NK/T-cell lymphoma and EBV-positive nodal T/NK-cell lymphoma and identify prognostic subgroups.

Leukemia·2026

EIF4A3-dependent nonsense-mediated decay buffers AML1-ETO9a dosage and modulates outcome in t(8;21) acute myeloid leukemia.

Leukemia·2026

Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.

Leukemia·2026

PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation.

Leukemia·2026

Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms.

Leukemia·2026

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

Leukemia·2026

Impact of antegrade selective cerebral perfusion flow ranges on clinical and neurological outcomes in aortic arch surgery.

Interdisciplinary cardiovascular and thoracic surgery·2026

Velocimetry based on multiphase CCTA images for reliable coronary flow velocity quantification across stenosis severities and ischemia detection.

Medical physics·2026

A fully integrated and automated 24-sample microfluidic system for sample-in-amplicon-out forensic analysis.

Microsystems & nanoengineering·2026

High-throughput viral enumeration of aquatic ecosystems via flow cytometry.

Applied and environmental microbiology·2026

The ACS at 150: The History of Analytical Chemistry Publications and a Century of Progress.

Analytical chemistry·2026

ACCURACY OF 2D FACIAL PROFILE PHOTOGRAPHS UNDER ROUTINE CLINICAL CONDITIONS COMPARED WITH 3D IMAGING.

Journal of dentistry·2026

Related Experiment Videos

X-inactivation analysis in the 1990s: promise and potential problems

Related Concept Videos

Impact of clonal hematopoiesis on cardiovascular outcomes in cancer patients of the UK Biobank.

Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients.

Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients.

Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation.

Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms.

EXEL-8232, a small-molecule JAK2 inhibitor, effectively treats thrombocytosis and extramedullary hematopoiesis in a murine model of myeloproliferative neoplasm induced by MPLW515L.

DNA methylation signatures distinguish extranodal NK/T-cell lymphoma and EBV-positive nodal T/NK-cell lymphoma and identify prognostic subgroups.

EIF4A3-dependent nonsense-mediated decay buffers AML1-ETO9a dosage and modulates outcome in t(8;21) acute myeloid leukemia.

Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.

PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation.

Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms.

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

Impact of antegrade selective cerebral perfusion flow ranges on clinical and neurological outcomes in aortic arch surgery.

Velocimetry based on multiphase CCTA images for reliable coronary flow velocity quantification across stenosis severities and ischemia detection.

A fully integrated and automated 24-sample microfluidic system for sample-in-amplicon-out forensic analysis.

High-throughput viral enumeration of aquatic ecosystems via flow cytometry.

The ACS at 150: The History of Analytical Chemistry Publications and a Century of Progress.

ACCURACY OF 2D FACIAL PROFILE PHOTOGRAPHS UNDER ROUTINE CLINICAL CONDITIONS COMPARED WITH 3D IMAGING.

Related Experiment Videos

X-inactivation analysis in the 1990s: promise and potential problems

Related Concept Videos

Related Articles